Event news
The 29th Montreux Symposium on LC–MS will take place on 7–9 November 2012 in Montreux, Switzerland.
LC–MS is continuously growing and this is reflected by the participation of over 30 nationalities and scientific contributions from a variety of application areas. These include food, pharmaceutical, biotechnological and environmental and research on novel instrumentation and new LC–MS fields such as nanotechnology and microfluidics, UHPLC, low flow-rate spray techniques, proteomics and systems biology.
In collaboration with the Metabolomics Society, a special joint parallel programme for this rapidly emerging field is being organized, addressing the technology as well as novel systems-based biology approaches in pharma, nutrition, clinical chemistry, plant sciences and medical biology. A parallel programme is being organized in collaboration with various clinical chemistry societies focusing on current and future LC–MS options in clinical diagnosis. Accreditation by related societies for the programme as well as the short course has been applied for
A number of invited and keynote lectures will provide new insights and a future outlook of key domains.
The "Roland W. Frei" opening lecture will be delivered by Professor Jan Smeitink from the Centre for Systems Biology and Bioenergetics (CSBB) of UMC St Radboud, Nijmegen University, Nijmegen, Netherlands addressing "Omics technologies and Bioenergetics: Application to Human Disease".
Plenary and keynote lectures will be given by:
As usual a large variety of poster and other oral contributions will build a strong and interesting programme for anyone working in LC–MS, metabolomics and clinical chemistry.
The International Association of Environmental Analytical Chemistry will be conferring the Roland W. Frei Award for the best poster presentation by a young scientist.
Prior to the conference from 5–6 November 2012 a series of short courses is organized. These introductory courses are focused on an introduction and advanced LC–MS technology, mass spectrometry LC–MS interpretation and a special new course on "Clinical Chemistry, LC–MS and Metabolomics".
Website: www.lcms-montreux.com
E-mail: lcms-2012@science.leidenuniv.nl
September–October 2012
Solutions for the Analysis and Characterization of Biomolecules
Organizers: Agilent Technologies
Location Various venues in Denmark, France, Germany, Ireland, Switzerland Website: www.biopharmaseminar.com
9–13 September 2012
29th International Symposium on Chromatography
Nicolaus Copernicus University Campus, Torun, Poland
Contact: Polish Chemical Society/Commission for Chromatographic Analysis
Tel: +48 56 6114308
E-mail: symposium@isc2012.pl
Website: www.isc2012.pl
24–26 September 2012
ExTech 2012, 14th Symposium on Advances in Extraction Technologies
University of Messina, Italy
Organizers: Luigi Mondello, Chromaleont, University of Messina, Italy
Tel: +39 0906766536
Fax: +39 090 358220
E-mail: extech@chromaleont.it
Website: www.chromaleont.it/extech
3–5 October 2012
SFC 2012 – 6th International Conference on Packed Column SFC
Brussels, Belgium
Organizers: The Green Chemistry Group
Tel: +1 412 805 6296
Fax: +1 412 967 9446
E-mail: register@greenchemistrygroup.org
Website: www.greenchemistrygroup.org
7–8 November 2012
Water Wastewater and Environmental Monitoring, Exhibition and Workshops (WWEM) 2012
Telford International Centre, Telford, UK
Organizers: International Labmate Ltd David Hellyer, exhibitions manager
Tel: +44(0)1727858840
Fax: +44(0)1727840310
E-mail: david@wwem.uk.com
Website: www.wwem.uk.com
Send any event news to Kate Mosford kmosford@advanstar.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.